V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004820 | 300006217 | 1.73 | 75.7 | Adjuvant (A) | 2018-04-14 | 2018-04-14 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 2 | N | 300025705 | CETUXIMAB + CISPLATIN + FU |
| 300004821 | 300003323 | 1.75 | 72 | Palliative (P) | 2016-07-10 | 2016-01-13 | Carboplatin AUC 2 - 5 | N | N | 300025706 | CAPECITABINE + OXALIPLATIN |
| 300004822 | 300003324 | 1.72 | 92.45 | Palliative (P) | 2014-03-05 | 2014-03-05 | PEMBROLIZUMAB | 02 | null | 300025708 | HYDROXYCARBAMIDE |
| 300004823 | 300003324 | 1.82 | 0 | null | 2017-10-05 | 2017-10-30 | DE-ESCALATE TRIAL | 02 | N | 300025708 | PEMBROLIZUMAB |
| 300004824 | 300003324 | null | null | Neo-adjuvant (N) | 2014-02-05 | 2014-02-05 | Folfirinox | 02 | null | 300025708 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004825 | 300003324 | 1.68 | 42.8 | Neo-adjuvant (N) | 2014-08-12 | 2014-08-15 | Folfirinox | 02 | null | 300025708 | FLUOROURACIL + MITOMYCIN + RT |
| 300004826 | 300003325 | 1.67 | 81 | Disease modification (D) | 2016-05-14 | 2016-06-01 | PEMBROLIZUMAB | 02 | N | 300025719 | CARBOPLATIN |
| 300004827 | 300003325 | 1.77 | 67.1 | Palliative (P) | 2016-12-28 | 2017-01-03 | Gemcitabine + Capecitabine | N | N | 300025719 | CARBOPLATIN |
| 300004828 | 300003325 | 1.8 | 92.1 | Not known (9) | 2015-12-09 | 2015-12-18 | Carboplatin + Etoposide iv&po | null | null | 300025719 | GEMCARBO |
| 300004829 | 300003325 | 1.77 | 94 | Curative (C) | 2015-01-01 | 2015-02-03 | Gemcitabine + Capecitabine | Y | Y | 300025719 | ESPAC TRIAL |
| 300004830 | 300003326 | 1.67 | 81.1 | null | 2016-04-29 | 2016-05-07 | Carbo F | null | N | 300025755 | CARBOPLATIN + VINORELBINE |
| 300004831 | 300003327 | 1.6 | 91 | Adjuvant (A) | 2014-11-17 | 2014-11-28 | Fluorouracil + Folinic Acid (Mayo) | 01 | N | 300025764 | ESPAC TRIAL |
| 300004832 | 300003327 | null | 60.7 | Curative (C) | 2014-07-12 | 2014-07-18 | MAESTRO TRIAL | 02 | null | 300025764 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300004833 | 300003328 | 1.51 | 100 | Palliative (P) | 2016-05-12 | 2015-08-06 | FLUOROURACIL | N | N | 300025775 | IPILIMUMAB + NIVOLUMAB |
| 300004834 | 300006221 | 0 | 71.8 | Curative (C) | 2013-07-02 | 2013-07-10 | Temozolomide 150mg/m2 | 02 | Y | 300025778 | CARBO + FLUOROURACIL |
| 300004835 | 300003329 | 1.65 | 93 | Curative (C) | 2017-02-05 | 2017-04-09 | FLUOROURACIL + MITOMYCIN | N | N | 300025780 | CARBOPLATIN + ETOPOSIDE |
| 300004840 | 300003332 | 1.59 | 66.5 | Neo-adjuvant (N) | 2014-04-05 | 2014-04-06 | GemCarbo Days 1+8 | 2 | N | 300025795 | IPILIMUMAB + NIVOLUMAB |
| 300004841 | 300006223 | 1.73 | 74.8 | Palliative (P) | 2015-10-13 | 2015-10-21 | IPILIMUMAB + NIVOLUMAB | Y | N | 300025796 | GEMCARBO |
| 300004842 | 300003333 | 1.61 | 64.4 | Palliative (P) | 2017-09-28 | 2017-10-22 | FLUOROURACIL + MITOMYCIN + RT | N | N | 300025798 | CARBO + FLUOROURACIL |
| 300004843 | 300003333 | 1.61 | null | Palliative (P) | 2016-11-12 | 2016-12-08 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 300025798 | TEMOZOLOMIDE + RT |
| 300004844 | 300007510 | 1.58 | 54 | Curative (C) | 2015-06-23 | 2015-06-30 | Ipilimumab | 02 | N | 300025809 | CARBOPLATIN + ETOPOSIDE |
| 300004845 | 300003334 | 1.8 | 144 | Curative (C) | 2015-07-11 | 2015-08-04 | FLUOROURACIL + OXALIPLATIN | Y | Y | 300025813 | OXALIPLATIN + MDG |
| 300004846 | 300003334 | 1.6 | 82.7 | null | 2013-07-08 | 2013-07-08 | Gemcitabine + Capecitabine | 02 | Y | 300025813 | CARBOPLATIN + ETOPOSIDE |
| 300004847 | 300003335 | 1.75 | 81 | Curative (C) | 2017-07-09 | 2017-07-09 | ESPAC-4 TRIAL | N | N | 300025821 | DE-ESCALATE TRIAL |
| 300004848 | 300003336 | 1.52 | 59.4 | Not known (9) | 2018-01-24 | 2018-02-06 | Capecitabine + Oxaliplatin 21day | 02 | null | 300025827 | OXALIPLATIN + MDG |
| 300004849 | 300003336 | 1.63 | 65 | Adjuvant (A) | 2015-02-23 | 2015-03-26 | PACLITAXEL | N | N | 300025827 | CARBOPLATIN + ETOPOSIDE |
| 300004850 | 300003336 | null | null | Palliative (P) | null | 2017-02-03 | GemCarbo Days 1+8 | 02 | N | 300025827 | PACLITAXEL |
| 300004851 | 300003336 | 1.65 | 72 | Palliative (P) | 2017-03-28 | 2017-04-15 | ESPAC-4 TRIAL | N | N | 300025827 | CISPLATIN + FLUOROURACIL + RT |
| 300004852 | 300003337 | null | 70 | Palliative (P) | 2017-06-20 | 2017-06-20 | Folfirinox | N | null | 300025862 | FLUOROURACIL + MITOMYCIN + RT |
| 300004853 | 300006227 | 1.63 | 72.2 | Adjuvant (A) | 2015-01-18 | 2015-01-19 | GemCarbo Days 1+8 | 02 | null | 300025866 | IPILIMUMAB + NIVOLUMAB |
| 300004854 | 300003338 | 1.7 | 75.7 | Palliative (P) | 2015-06-24 | 2015-06-28 | Folfirinox | N | N | 300025870 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004855 | 300003339 | null | 68 | Curative (C) | 2013-08-13 | 2013-08-14 | ESPAC-4 TRIAL | 2 | N | 300025872 | BCG |
| 300004856 | 300003340 | 1.82 | 90.5 | Palliative (P) | 2017-05-25 | 2017-06-03 | Folfirinox | 2 | N | 300025878 | CARBO + FLUOROURACIL |
| 300004858 | 300003342 | 1.72 | 88 | Palliative (P) | 2014-09-15 | 2014-09-21 | DABRAFENIB + TRAMETINIB | N | N | 300025885 | CISPLATIN + FLUOROURACIL + RT |
| 300004859 | 300003342 | 1.55 | 51.7 | Curative (C) | null | 2014-04-20 | PEMBROLIZUMAB | N | N | 300025885 | TRASTUZUMAB |
| 300004860 | 300003342 | null | 59.4 | Palliative (P) | 2014-03-24 | 2014-04-01 | Folfirinox | 02 | N | 300025885 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004861 | 300003343 | 1.69 | 74.8 | Curative (C) | 2014-10-18 | 2014-10-31 | Bevacizumab 7.5mg/kg | N | N | 300025901 | VAI |
| 300004862 | 300003343 | 1.67 | 54.2 | Palliative (P) | 2014-08-14 | 2014-08-27 | CARBOPLATIN | 02 | N | 300025901 | PEMBROLIZUMAB |
| 300004863 | 300003343 | 1.71 | -1 | Palliative (P) | null | 2017-07-22 | CARBOPLATIN + RT | N | N | 300025901 | ECARBOX |
| 300004864 | 300003344 | 1.67 | 79.6 | null | 2015-12-29 | 2015-12-29 | ESPAC-4 TRIAL | 2 | null | 300025914 | CAPECITABINE + OXALIPLATIN |
| 300004865 | 300003344 | 1.7 | 79.3 | Palliative (P) | 2018-02-18 | 2018-03-17 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | N | 300025914 | FLUOROURACIL |
| 300004866 | 300003345 | 1.63 | 63.4 | Neo-adjuvant (N) | 2013-10-15 | 2013-10-15 | Carboplatin + Etoposide iv&po | 02 | N | 300025923 | PACLITAXEL |
| 300004867 | 300003345 | 1.78 | 81.5 | Adjuvant (A) | 2014-07-26 | 2014-08-17 | FLUOROURACIL + MITOMYCIN + RT | N | N | 300025923 | CARBO + FLUOROURACIL |
| 300004869 | 300003347 | 1.73 | 94.05 | Curative (C) | 2014-07-11 | 2014-07-16 | Gemcitabine + Capecitabine | 02 | N | 300025938 | CARBOPLATIN + ETOPOSIDE |
| 300004870 | 300003348 | null | null | Adjuvant (A) | null | 2013-07-01 | ESPAC-4 TRIAL | null | null | 300025940 | PEMBROLIZUMAB |
| 300004871 | 300006232 | 1.82 | 106.9 | Neo-adjuvant (N) | 2016-11-08 | 2016-11-13 | CARBOPLATIN + FLUOROURACIL | N | N | 300025943 | CAPECITABINE + GEMCITABINE |
| 300004872 | 300003349 | 1.6 | 62 | Palliative (P) | 2016-06-02 | 2016-06-09 | Paclitaxel 7 day | 2 | N | 300025947 | FLUOROURACIL |
| 300004873 | 300003349 | null | 65.3 | Adjuvant (A) | 2014-03-21 | 2014-04-10 | Cisplatin + Vinorelbine (IV) | N | N | 300025947 | CAPECITABINE + MITOMYCIN |
| 300004874 | 300003349 | 1.7 | null | Palliative (P) | 2015-05-07 | 2015-05-09 | ESPAC-4 TRIAL | 02 | N | 300025947 | EOX |
| 300004875 | 300003350 | 1.92 | 104.2 | Curative (C) | null | 2014-04-24 | DE-ESCALATE TRIAL | N | Y | 300025959 | BEVACIZUMAB |